CA2167942A1 - Methode d'inhibition du sarcome de kaposi - Google Patents

Methode d'inhibition du sarcome de kaposi

Info

Publication number
CA2167942A1
CA2167942A1 CA002167942A CA2167942A CA2167942A1 CA 2167942 A1 CA2167942 A1 CA 2167942A1 CA 002167942 A CA002167942 A CA 002167942A CA 2167942 A CA2167942 A CA 2167942A CA 2167942 A1 CA2167942 A1 CA 2167942A1
Authority
CA
Canada
Prior art keywords
apoe
cells
kaposi
sarcoma
apolipoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002167942A
Other languages
English (en)
Inventor
Tikva Vogel
Robert C. Gallo
Philip J. Browning
David D. Roberts
Amos Panet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Savient Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2167942A1 publication Critical patent/CA2167942A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Amplifiers (AREA)

Abstract

L'invention concerne des procédés et des compositions comprenant de l'apolipoprotéine E pour inhiber la prolifération des cellules du sarcome de Kaposi. Cette invention concerne également un procédé de traitement d'un patient atteint du sarcome de Kaposi selon lequel on administre au patient une quantité d'une composition renfermant une dose d'apolipoprotéine E efficace pour traiter le sarcome de Kaposi et un excipient pharmaceutiquement acceptable.
CA002167942A 1993-08-12 1994-08-12 Methode d'inhibition du sarcome de kaposi Abandoned CA2167942A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10590093A 1993-08-12 1993-08-12
US08/105,900 1993-08-12

Publications (1)

Publication Number Publication Date
CA2167942A1 true CA2167942A1 (fr) 1995-02-23

Family

ID=22308419

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002167942A Abandoned CA2167942A1 (fr) 1993-08-12 1994-08-12 Methode d'inhibition du sarcome de kaposi

Country Status (6)

Country Link
EP (1) EP0715521A4 (fr)
AU (1) AU7526494A (fr)
CA (1) CA2167942A1 (fr)
IL (1) IL110638A0 (fr)
WO (1) WO1995005190A1 (fr)
ZA (1) ZA946090B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950702430A (ko) * 1992-08-12 1995-07-29 심파쓰 아포리포프로테인 이(Apolipoprotein E)를 이용한 세포증식 억제방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177189A (en) * 1989-08-18 1993-01-05 The Scripps Research Institute Polypeptide analogs of Apolipoprotein E
WO1993000443A1 (fr) * 1991-06-26 1993-01-07 Bio-Technology General Corp. Purification d'apolipoproteine e recombinante tiree de bacteries
KR950702430A (ko) * 1992-08-12 1995-07-29 심파쓰 아포리포프로테인 이(Apolipoprotein E)를 이용한 세포증식 억제방법

Also Published As

Publication number Publication date
EP0715521A4 (fr) 1998-01-14
IL110638A0 (en) 1994-11-11
EP0715521A1 (fr) 1996-06-12
WO1995005190A1 (fr) 1995-02-23
AU7526494A (en) 1995-03-14
ZA946090B (en) 1995-11-22

Similar Documents

Publication Publication Date Title
AU617126B2 (en) A polypeptide growth factor from milk
Woloski et al. Identification and partial characterization of hepatocyte-stimulating factor from leukemia cell lines: comparison with interleukin 1.
US7718604B2 (en) Use of IL-22 for the treatment of conditions of metabolic disorders
HRP960213A2 (en) RECOMBINANT OBESE (Ob) PROTEINS
US6191106B1 (en) Muteins of epidermal growth factor exhibiting enhanced binding at low pH
US5158935A (en) Human epidermal growth factor having substitution at position 11
EP0876152A1 (fr) Nouvelle administration de thrombopoietine
AU625807B2 (en) Uses of recombinant colony stimulating factor-1
AU1901501A (en) Antimcrobial activity of the first cationic cluster of human lactoferrin
CN115089698A (zh) 改善皮肤的活性肽与干细胞外泌体在药品或化妆品中的应用
AU673543B2 (en) Method of inhibiting cell proliferation using apolipoprotein E
US5616554A (en) Immune-enhancing agent for therapeutic use in immunocompromised hosts
US5725850A (en) Use of CSF-1 to treat tumor burden
CN101671390B (zh) 人干扰素α衍生物及其聚乙二醇化修饰物的制备和用途
CA2167942A1 (fr) Methode d'inhibition du sarcome de kaposi
JPH04506818A (ja) 造血細胞の成熟
JPH02157231A (ja) 細胞増殖抑制剤
WO1996011700A1 (fr) Utilisation de substances activatrices de la phospholipase a2 pour reduire les neoplasmes chez les mammiferes
EP0679659B1 (fr) Polypeptide a inhibition specifique de la cathepsine l
NZ506695A (en) Utilization of cd137 in order to promote the profileration of peripheral monocytes
Phillips et al. Correction of defective tumoricidal activity of macrophages from A/J mice by liposomal immunomodulators
JPH022391A (ja) ヒトｍ―ｃｓｆ及びその製造法
JP3580836B2 (ja) 好中球減少症治療剤
EP0475719A2 (fr) Peptide de régulation de la croissance derivé de plaquettes
SI8212335A8 (sl) Polipeptid s humanimi imunointerferonskimi (ifn-gama)lastnostmi

Legal Events

Date Code Title Description
FZDE Discontinued